https://app.sharelinktechnologies.com/announcement/asx/98cf683268722c4727291ef0b3fe40b0...
this really is a constructive involvement between immutep/fda/ema, ensuing recommendations
by regulatory authorities on trial design and direction....targeted direction at those likely to benefit
most from this treatment procedure..
Ann: Immutep receives FDA feedback for Efti development in MBC, page-38
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.8¢ |
Change
-0.013(3.91%) |
Mkt cap ! $450.3M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 30.5¢ | $101.2K | 326.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 213374 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 33869 | 8 |
View Market Depth
| Last trade - 11.42am 12/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |